189 related articles for article (PubMed ID: 2272314)
1. The malignant conversion step of mouse skin carcinogenesis.
Yuspa SH; Hennings H; Roop D; Strickland J; Greenhalgh DA
Environ Health Perspect; 1990 Aug; 88():193-5. PubMed ID: 2272314
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of malignant conversion in skin carcinogenesis.
Yuspa SH; Greenhalgh DA
Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
[TBL] [Abstract][Full Text] [Related]
3. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
4. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis.
Hennings H; Glick AB; Greenhalgh DA; Morgan DL; Strickland JE; Tennenbaum T; Yuspa SH
Proc Soc Exp Biol Med; 1993 Jan; 202(1):1-8. PubMed ID: 8424089
[TBL] [Abstract][Full Text] [Related]
5. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
[TBL] [Abstract][Full Text] [Related]
6. Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene.
Greenhalgh DA; Yuspa SH
Mol Carcinog; 1988; 1(2):134-43. PubMed ID: 2475137
[TBL] [Abstract][Full Text] [Related]
7. Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma.
Greenhalgh DA; Welty DJ; Player A; Yuspa SH
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):643-7. PubMed ID: 2153961
[TBL] [Abstract][Full Text] [Related]
8. Transfection of the EJ rasHa gene into keratinocytes derived from carcinogen-induced mouse papillomas causes malignant progression.
Harper JR; Roop DR; Yuspa SH
Mol Cell Biol; 1986 Sep; 6(9):3144-9. PubMed ID: 2431297
[TBL] [Abstract][Full Text] [Related]
9. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression during multistage carcinogenesis.
Bowden GT; Krieg P
Environ Health Perspect; 1991 Jun; 93():51-6. PubMed ID: 1773801
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
[TBL] [Abstract][Full Text] [Related]
13. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors.
Nelson MA; Futscher BW; Kinsella T; Wymer J; Bowden GT
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6398-402. PubMed ID: 1352887
[TBL] [Abstract][Full Text] [Related]
14. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
15. cHa-ras proto-oncogene. Amplification and overexpression in UV-B-induced mouse skin papillomas and carcinomas.
Husain Z; Yang QM; Biswas DK
Arch Dermatol; 1990 Mar; 126(3):324-30. PubMed ID: 2178557
[TBL] [Abstract][Full Text] [Related]
16. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
[TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
19. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between Ha-ras and fos or transforming growth factor alpha overcomes a paradoxic tumor-inhibitory effect of p53 loss in transgenic mouse epidermis.
Wang XJ; Greenhalgh DA; Donehower LA; Roop DR
Mol Carcinog; 2000 Oct; 29(2):67-75. PubMed ID: 11074603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
